Domainex Improves Fragment Based Drug Discovery Services
Addition of Monolith NT from NanoTemper Technologies Ltd. enables Domainex to offer a unique protein production, characterisation, and fragment screening service.Read more
Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.
A Knowledge Bank to Inform Personalised Cancer Treatment
A proof-of-concept study using data from 1540 AML patients shows that truly personalised cancer therapy will be possible in the future.Read more